Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Cognitive performance and peripheral endocannabinoid system receptor expression in schizophrenia.

Ferretjans R, de Campos SM, Ribeiro-Santos R, Guimarães FC, de Oliveira K, Cardoso AC, Araújo MS, Teixeira-Carvalho A, Martins-Filho OA, Teixeira AL, Salgado JV.

Schizophr Res. 2014 Jul;156(2-3):254-60. doi: 10.1016/j.schres.2014.04.028. Epub 2014 May 20.

PMID:
24853061
2.

Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: Evidence for defective immunomodulatory mechanisms.

de Campos-Carli SM, Araújo MS, de Oliveira Silveira AC, de Rezende VB, Rocha NP, Ferretjans R, Ribeiro-Santos R, Teixeira-Carvalho A, Martins-Filho OA, Berk M, Salgado JV, Teixeira AL.

J Psychiatr Res. 2017 Apr;87:44-52. doi: 10.1016/j.jpsychires.2016.12.001. Epub 2016 Dec 3.

PMID:
28011441
3.

Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells.

Jean-Gilles L, Braitch M, Latif ML, Aram J, Fahey AJ, Edwards LJ, Robins RA, Tanasescu R, Tighe PJ, Gran B, Showe LC, Alexander SP, Chapman V, Kendall DA, Constantinescu CS.

Acta Physiol (Oxf). 2015 May;214(1):63-74. doi: 10.1111/apha.12474. Epub 2015 Mar 10.

4.

Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia.

Fakhoury M.

Mol Neurobiol. 2017 Jan;54(1):768-778. doi: 10.1007/s12035-016-9697-5. Epub 2016 Jan 15. Review.

PMID:
26768595
5.

The endocannabinoid system in peripheral lymphocytes as a mirror of neuroinflammatory diseases.

Centonze D, Battistini L, Maccarrone M.

Curr Pharm Des. 2008;14(23):2370-42. Review.

PMID:
18781987
6.

Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia.

Chase KA, Feiner B, Rosen C, Gavin DP, Sharma RP.

Psychiatry Res. 2016 Nov 30;245:346-353. doi: 10.1016/j.psychres.2016.08.055. Epub 2016 Aug 24.

PMID:
27591408
7.

Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor.

Minocci D, Massei J, Martino A, Milianti M, Piz L, Di Bello D, Sbrana A, Martinotti E, Rossi AM, Nieri P.

J Affect Disord. 2011 Nov;134(1-3):427-30. doi: 10.1016/j.jad.2011.05.023. Epub 2011 Jun 11.

PMID:
21658778
8.

Effects of targeted deletion of cannabinoid receptors CB1 and CB2 on immune competence and sensitivity to immune modulation by Delta9-tetrahydrocannabinol.

Springs AE, Karmaus PW, Crawford RB, Kaplan BL, Kaminski NE.

J Leukoc Biol. 2008 Dec;84(6):1574-84. doi: 10.1189/jlb.0508282. Epub 2008 Sep 12.

9.

Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.

Benito C, Romero JP, Tolón RM, Clemente D, Docagne F, Hillard CJ, Guaza C, Romero J.

J Neurosci. 2007 Feb 28;27(9):2396-402.

10.

Expression and localization of cannabinoid receptors in human immature oocytes and unfertilized metaphase-II oocytes.

Peralta L, Agirregoitia E, Mendoza R, Expósito A, Casis L, Matorras R, Agirregoitia N.

Reprod Biomed Online. 2011 Sep;23(3):372-9. doi: 10.1016/j.rbmo.2011.05.011. Epub 2011 May 26.

PMID:
21778114
11.

The leukocytes expressing DARPP-32 are reduced in patients with schizophrenia and bipolar disorder.

Torres KC, Souza BR, Miranda DM, Nicolato R, Neves FS, Barros AG, Dutra WO, Gollob KJ, Correa H, Romano-Silva MA.

Prog Neuropsychopharmacol Biol Psychiatry. 2009 Mar 17;33(2):214-9. doi: 10.1016/j.pnpbp.2008.10.020. Epub 2008 Nov 8.

PMID:
19059449
12.

Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear.

Choi K, Le T, McGuire J, Xing G, Zhang L, Li H, Parker CC, Johnson LR, Ursano RJ.

J Psychiatr Res. 2012 Jul;46(7):882-9. doi: 10.1016/j.jpsychires.2012.03.021. Epub 2012 Apr 23.

PMID:
22534181
13.

Altered neural signaling and immune pathways in peripheral blood mononuclear cells of schizophrenia patients with cognitive impairment: A transcriptome analysis.

Wu JQ, Green MJ, Gardiner EJ, Tooney PA, Scott RJ, Carr VJ, Cairns MJ.

Brain Behav Immun. 2016 Mar;53:194-206. doi: 10.1016/j.bbi.2015.12.010. Epub 2015 Dec 14.

PMID:
26697997
14.
15.

Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by interferon-β: a longitudinal study in multiple sclerosis patients.

Sánchez López AJ, Román-Vega L, Ramil Tojeiro E, Giuffrida A, García-Merino A.

Clin Exp Immunol. 2015 Jan;179(1):119-27. doi: 10.1111/cei.12443.

16.
17.

Regulation of opioid and cannabinoid receptor genes in human neuroblastoma and T cells by the epigenetic modifiers trichostatin A and 5-aza-2'-deoxycytidine.

Börner C, Martella E, Höllt V, Kraus J.

Neuroimmunomodulation. 2012;19(3):180-6. doi: 10.1159/000331474. Epub 2012 Jan 18.

PMID:
22262103
18.

Changes in CB(1) and CB(2) receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias.

Rodríguez-Cueto C, Benito C, Fernández-Ruiz J, Romero J, Hernández-Gálvez M, Gómez-Ruiz M.

Br J Pharmacol. 2014 Mar;171(6):1472-89. doi: 10.1111/bph.12283.

19.

Cannabinoid receptor type 2, but not type 1, is up-regulated in peripheral blood mononuclear cells of children affected by autistic disorders.

Siniscalco D, Sapone A, Giordano C, Cirillo A, de Magistris L, Rossi F, Fasano A, Bradstreet JJ, Maione S, Antonucci N.

J Autism Dev Disord. 2013 Nov;43(11):2686-95. doi: 10.1007/s10803-013-1824-9.

PMID:
23585028
20.

[Peripheral blood T-lymphocyte and T-lymphocyte subset ratios before and after treatment in schizophrenia patients not taking antipsychotic medication].

Baskak SC, Ozsan H, Baskak B, Devrimci Ozgüven H, Kinikli G.

Turk Psikiyatri Derg. 2008 Spring;19(1):5-12. Turkish.

Supplemental Content

Support Center